Skip to main content
Clinical Trials/NCT07182448
NCT07182448CompletedNot Applicable

Interaction of Hypoxia and Kynurenine Pathway in Periodontal Inflammation

Istanbul Medipol University Hospital1 site in 1 country45 target enrollmentStarted: February 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
45
Locations
1
Primary Endpoint
Pocket probing depth

Study Overview

Brief Summary

The kynurenine pathway (KP), the primary route for tryptophan (TRP) metabolism, is activated during inflammation and hypoxic conditions, contributing to immune dysregulation and oxidative stress. the interconnected roles of hypoxia, KP activation, and oxidative stress in periodontitis have not been comprehensively investigated.The aim of this study was to determine the role of the kynurenine (KYN) pathway and hypoxia in periodontal inflammation, as well as their association with periodontal clinical parameters.

Detailed Description

Systemically healthy 23 stage III, grade B periodontitis patients and 22 periodontally healthy individuals were included in this study. Salivary and serum tumor necrosis factor-alpha (TNF-α), hypoxia-inducible factor-1 alpha (HIF-1α) and 8-hydroxy-2'-deoxyguanosine (8-OhdG) levels were evaluated by ELISA, and salivary and serum KP metabolites were evaluated by liquid chromatography-mass spectrometry.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •systemically healthy
  • •clinical diagnosis of periodontitis
  • •clinical diagnosis of periodontal health

Exclusion Criteria

  • •decline to participate and being under 18 & over 65 years of age;
  • •having any systemic inflammatory diseases such as diabetes, rheumatoid arthritis, or systemic conditions, including immunodeficiency syndrome, cardiovascular disorders, or hepatic disorders;
  • •the use of antibiotics and/or anti-inflammatory nonsteroidal anti-inflammatory drugs within 3 months preceding the study;
  • •having nonsurgical periodontal treatment (previous 6 months);
  • •having surgical periodontal treatment (previous 12 months);
  • •having <20 natural teeth excluding the third molars.

Outcomes

Primary Outcomes

Pocket probing depth

Time Frame: 3 months

Measurement of the depth of a sulcus or periodontal pocket determined by measuring distance from a gingival margin to the base of the sulcus or pocket with a calibrated periodontal probe

Clinical attachment level

Time Frame: 4 months

Clinical attachment level (or loss, CAL) is a more accurate indicator of the periodontal support around a tooth than probing depth alone. CAL is measured from a fixed point on the tooth that does not change, the CEJ. To calculate CAL, two measurements are needed: distance from the gingival margin to the CEJ and probing depth. In recession: probing depth (+) gingival margin to the CEJ (add). In tissue overgrowth: probing depth (-) gingival margin to the CEJ (subtract)

Bleeding on probing

Time Frame: 4 months

Bleeding on probing referring to bleeding that is induced by gentle manipulation of the tissue at the depth of the gingival sulcus, or interface between the gingiva and a tooth

Secondary Outcomes

  • serum and saliva analyses for selected molecules(3 months)

Investigators

Sponsor
Istanbul Medipol University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Nur Balci, DDs, PhD

Clinical Prof

Istanbul Medipol University Hospital

Study Sites (1)

Loading locations...

Similar Trials

Hypoxia and Kynurenine Pathway in... | Clinical Trial